Montis Financial’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Buy
522
+6
+1% +$3.37K 0.06% 132
2026
Q1
$290K Buy
516
+59
+13% +$37.8K 0.06% 128
2025
Q4
$309K Buy
457
+8
+2% +$5.45K 0.06% 124
2025
Q3
$287K Buy
+449
New +$273K 0.07% 129
2022
Q1
Sell
-323
Closed -$213K 76
2021
Q4
$213K Buy
+323
New +$203K 0.15% 83
2021
Q3
Sell
-377
Closed -$238K 69
2021
Q2
$238K Buy
+377
New +$208K 0.2% 62

Other funds holding IDXX

Montis Financial's IDXX Position: Q2 2026 in Review

Montis Financial increased its Idexx Laboratories (IDXX) stake by 1.2% in Q2 2026, buying an estimated $3.37K and bringing the position to 522 shares worth $275K. The position accounts for 0.06% of the portfolio, ranked #132.

Montis Financial first reported a position in IDXX in Q2 2021 and has held it in 6 quarters since. The position peaked at $309K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Montis Financial held 522 shares of Idexx Laboratories worth $275K as of Q2 2026.
  • Montis Financial bought 6 Idexx Laboratories shares in Q2 2026, an estimated $3.37K.
  • Idexx Laboratories made up 0.06% of Montis Financial's portfolio in Q2 2026, its #132 holding.
  • Montis Financial first reported a position in Idexx Laboratories in Q2 2021 and has held it in 6 quarters since.
  • Montis Financial's Idexx Laboratories position peaked at $309K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Montis Financial's 13F filing for Q2 2026, filed 6 Aug 2026.